Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 25, 2024 5:00 P.M.
Form: S-1
CIK: 0001868279
Company Name: ArriVent Biopharma, Inc.
File Number: 333-276397